Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep484 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Flash glucose monitoring system: Impact on glycaemic control and body mass index in type 1 diabetes mellitus

Sá Juliana , Lopes Sara , Barbosa Mariana , Ferreira Barros Inês , Margarida Monteiro Ana , Fernandes Vera , Matos Catarina , Alves Marta , Lopes Pereira Maria , Marques Olinda , Joana Santos Maria

Background: The use of Flash Glucose Monitoring (FGM) for the management of type 1 diabetes mellitus (T1D) is rapidly increasing.Aims: To assess the longitudinal evolution of glycated haemoglobin (HbA1c) and body mass index (BMI) with the use of FGM in patients with T1D; to determine predictive factors of benefit with the use of this technology.Materials and methods: Retrospective study of T1D patients, using FGM ≥6 months an...

ea0070aep595 | Pituitary and Neuroendocrinology | ECE2020

Gallium-68 -DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas

M. Boertien Tessel , Booij Jan , Majoie Charles BLM , Drent ML , Pereira Alberto M , Biermasz Nienke , Simsek Suat , Groote Veldman Ronald , Stokkel Marcel PM , Bisschop Peter H , Fliers Eric

Background: Clinically non-functioning pituitary macroadenomas (NFMA) have been reported to express various somatostatin receptor (SSTR) subtypes, but results are inconsistent across different studies. This may be related to limited sensitivity and specificity of techniques used to date, i.e. immunohistochemistry in surgical specimens and 111In-DTPA-octreotide scintigraphy (Octreoscan) in vivo. The aim of this study was to assess SSTR expression in NFMA <em...

ea0070aep753 | Pituitary and Neuroendocrinology | ECE2020

SF-12 or SF-36 in pituitary disease? towards concise patient-reported outcomes measurements

Van der Meulen Merel , Biermasz Nienke , Zamanipoor Najafabadi Amir , Lobatto Daniel , van Furth Wouter , Andela Cornelie , Pereira Alberto M , Vliet-Vlieland Thea P.M.

Objective: Pituitary diseases cause a wide range of local and systemic symptoms and severely affect patients’ health-related quality of life (HRQoL), which can be monitored using both disease-specific and generic questionnaires. The most frequently used generic HRQoL questionnaire is the Short Form-36 (SF-36), generating a mental (MCS) and physical component score (PCS). The shorter 12-item version (SF-12) can improve efficiency of patient monitoring and outcome measurem...

ea0070aep911 | Thyroid | ECE2020

Insulin resistance, lipid profile and low-grade inflammation in Hashimoto thyroiditis

Afonso Marta , Neves Celestino , Sérgio Neves João , Pereira Miguel , Luís Medina José , Delgado Luís , Carvalho Davide

Background: Hashimoto thyroiditis (HT) is the most common autoimmune disease and patients may present different levels of thyroid dysfunction. The association between hypothyroidism and cardiovascular events is well established. However, it remains unclear how mild thyroid dysfunction, autoimmunity and chronic inflammation in HT contribute to an increased cardiovascular risk in euthyroid patients and in subclinical hypothyrodism. Therefore, this study aims to assess insulin re...

ea0070aep1076 | Hot topics (including COVID-19) | ECE2020

Outcome squares integrating efficacy and safety, as applied to functioning pituitary adenoma surgery

de Vries Friso , Lobatto Daniel , Verstegen Marco , Schutte Pieter , Notting Irene , Kruit Mark , Ahmed Fasial , Pereira Alberto M , van Furth Wouter , Biermasz Nienke

Background: Transsphenoidal surgery is standard care in the treatment of hormone-secreting pituitary adenomas. Current clinician-reported surgical outcome measures are one-dimensional, typically focussing primarily on complete or partial resection and secondarily on complication rates. However, outcomes are best reflected by the delicate balance of efficacy and complications at patient level. This study proposes a novel way to classify outcome, integrating efficacy and safety ...

ea0032p396 | Diabetes | ECE2013

Quality of care in diabetic patients

Marcelino Mafalda , Domingues Andreia , Pereira Armando , Passos Dolores , Raimundo Joaquim , Silva Joao , Lopes Luis , Lopes Maria , Chambel Paula , Santos Valentim , de Castro Joao Jacome

Introduction: Type 2 diabetes mellitus (T2DM) is a chronic disease, with prevalence increasing worldwide and its complications are major causes of early morbidity and mortality. Recent guidelines suggest the individualisation of glycaemic targets and glucose-lowering therapies.The aim of this study was to determine the quality of care provided to type 2 diabetic patients in our institution, analysing metabolic control, cardiovascular risk factors and pre...

ea0032p499 | Endocrine disruptors | ECE2013

Tributyltin changes the thyroid gland morphology of male rats

Pereira Paula Rodrigues , Mattos Romulo Medina de , Palmero Celia Yelimar , Fortunato Rodrigo , Gracelli Jones Bernardes , Carvalho Denise Pires de , Nasciutti Luiz Eurico , Miranda-Alves Leandro

Triorganotins, such as tributyltin (TBT), are environmental contaminants commonly found in antifouling paints that are used on the ships and other vessels. Unfortunately, these chemical are also suspected to cause endocrine-disrupting effects in mammals, due in part to their possible transfer through marine food chains and to the consumption of contaminated seafood. The importance of triorganotins as environmental endocrine disruptors in different animal models is well known; ...

ea0032p797 | Paediatric endocrinology | ECE2013

Improvement in metabolic control of type 1 diabetes mellitus in a tertiary unit: 2005 vs 2012

Caetano Joana , Ferreira Sara , Pereira Ester , Ferreira Marta , Lourenco Helena , Aveiro Lina , Batista Nanci , Freitas Filomena , Simao Luisa , Cardoso Rita , Dinis Isabel , Mirante Alice

Aim: To define the main predictors of metabolic control in children and adolescents and evaluate its improvement along the years.Methods: We included children and adolescents with 1DM, with more than two years of disease. Data were collected at 2005 and at 2012. Sex, age and severity at diagnosis, therapy in the last year, age at onset of multiple daily insulin injections (MDII) and continuous subcutaneous insulin infusion (CSII), number of group educati...

ea0032p1022 | Thyroid (non-cancer) | ECE2013

IgG4-related Hashimoto's thyroiditis: an emerging variant of a well known disease

Luiz Henrique , Goncalves Diogo , Pereira Bernardo , da Silva Tiago , Veloza Andreia , Matos Catarina , Manita Isabel , Cordeiro Maria , Raimundo Luisa , Oliveira Ana , Brito Maria , Portugal Jorge

Introduction: IgG4-related Hashimoto’s thyroiditis (HT) is a very recently reported entity, characterized by thyroid inflammation rich in IgG4-positive plasma cells associated with marked fibrosis. It may be part of the systemic IgG4-related sclerosing disease and is associated with younger age, lower female:male ratio, higher levels of thyroid autoantibodies, low echogenicity on ultrasound (US), rapid progress requiring surgery and more subclinical hypothyroidism, when c...

ea0032p1045 | Thyroid (non-cancer) | ECE2013

Graves' disease and cardiovascular risk factors

Brandao Carla , Neves Celestino , Palmares Carmo , Sokhatska Oksana , Esteves Cesar , Dias Camila , Pereira Miguel , Delgado Luis , Carvalho Davide , Medina Jose Luis

Objective: To evaluate the interrelationships between Graves’ disease (GD) and cardiovascular risk factors.Subjects and methods: We analyzed thyroid function tests, anti-thyroid antibodies, BMI, insulin resistance markers, namely homeostasis model assessment for insulin resistance (HOMA-IR and HOMA-B), the quantitative insulin sensitivity check index (QUICKI), hepatic insulin sensitivity index (HISI), whole-body insulin sensitivity index (WBISI), in...